Cardiovascular in vitro and ex vivo models enable the investigation of complex biological processes in a controlled environment that mimics human physiology, thereby providing critical insights into cardiac function, disease mechanisms, and drug responses. TCDM offers expertise in advanced modelling techniques to study cardiovascular diseases, focusing on human-induced pluripotent stem cell (hiPSC)-derived cardiac cells and isolated heart preparations. We provide researchers with expertise and services to investigate for example cardiac hypertrophy, drug cardiotoxicity, cardiac contractility, and genetic cardiac diseases.
